March 10, 2020 / 8:13 PM / in 24 days

BRIEF-Protagonist Therapeutics Posts Quarterly Loss Per Share Of $0.63

March 10 (Reuters) - Protagonist Therapeutics Inc:

* PROTAGONIST THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.63

* Q4 EARNINGS PER SHARE ESTIMATE $-0.65 — REFINITIV IBES DATA

* SUFFICIENT FINANCIAL RESOURCES TO SUPPORT DEVELOPMENT OF PIPELINE ASSETS THROUGH END OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below